Botulinum Toxin A in Upper Limb Spasticity Management: Changing Clinical Practice. Data from the Upper Limb International Spasticity (ULIS)

被引：0
|
作者：
Turner-Stokes, Lynne [1 ]
Ashford, Stephen [1 ]
Fheodoroff, Klemens [2 ]
Jacinto, Jorge [3 ]
Brashear, Allison [4 ]
Maisonobe, Pascal [5 ]
Lysandropoulos, Andreas [6 ]
机构：
[1] Kings Coll London, Sch Med, Palliat Care Policy & Rehabil & Reg Rehabil Unit, Northwick Pk Hosp, London, England
[2] Gailtal Klin, Dept Neurorehabil, Hermagor, Austria
[3] Ctr Med Reabilitacaode Alcoitao, Serv Reabilitacao Adultos, Estoril, Portugal
[4] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC USA
[5] Ipsen Pharma, Biometry, Boulogne, France
[6] Ipsen Pharma, Global Med Affairs, Boulogne, France
来源：
BRAIN INJURY | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
0508
引用
收藏
页码：191 / 192
页数：2
相关论文
共 50 条
  • [1] Time to retreatment with botulinum toxin A in upper limb spasticity management: Initial data from the Upper Limb International Spasticity (ULIS)-III Study
    Turner-Stokes, L.
    Ashford, S.
    Jacinto, J.
    Fheodoroff, K.
    Suarez, G.
    Maisonobe, P.
    MOVEMENT DISORDERS, 2017, 32
  • [2] MANAGEMENT OF UPPER LIMB SPASTICITY WITH BOTULINUM TOXIN A: BASELINE DATA FROM THE ITALIAN COHORT OF THE UPPER LIMB INTERNATIONAL SPASTICITY (ULIS)-III STUDY
    Millevolte, Marzia
    Cosma, Michela
    Manca, Mario
    Molteni, Franco
    Diverio, Manuela
    Girlanda, Paolo
    Ianeri, Giancarlo
    Maisonobe, Pascal
    Caglioni, Patrizia Maria
    Caltagirone, Carlo
    TOXICON, 2018, 156 : S80 - S81
  • [3] TIME TO RETREATMENT WITH BOTULINUM TOXIN A IN UPPER LIMB SPASTICITY MANAGEMENT: UPPER LIMB INTERNATIONAL SPASTICITY (ULIS)-III STUDY INTERIM ANALYSIS
    Turner-Stokes, Lynne
    Ashford, Stephen
    Fheodoroff, Klemens
    Brashear, Allison
    Maisonobe, Pascal
    Lysandropoulos, Andreas
    Jacinto, Jorge
    TOXICON, 2018, 156 : S110 - S111
  • [4] Botulinum toxin A for upper limb spasticity
    Kwakkel, Gert
    Meskers, Carel G. M.
    LANCET NEUROLOGY, 2015, 14 (10): : 969 - +
  • [5] Goal setting for botulinum toxin injections: Impact of the Upper Limb International Spasticity (ULIS) programme
    Fheodoroff, K.
    Ashford, S.
    Jacinto, J.
    Brashear, A.
    Maisonobe, P.
    Lysandropoulos, A.
    Turner-Stokes, L.
    MOVEMENT DISORDERS, 2019, 34 : S558 - S558
  • [6] Botulinum Toxin A in the management of upper limb spasticity in cerebral palsy
    Chin, TYP
    Graham, HK
    HAND CLINICS, 2003, 19 (04) : 591 - +
  • [7] LONGITUDINAL GOAL ATTAINMENT WITH INTEGRATED UPPER LIMB SPASTICITY MANAGEMENT INCLUDING REPEAT INJECTIONS OF BOTULINUM TOXIN A: FINDINGS FROM THE PROSPECTIVE, OBSERVATIONAL UPPER LIMB INTERNATIONAL SPASTICITY (ULIS-III) COHORT STUDY
    Turner-Stokes, Lynne
    Jacinto, Jorge
    Fheodoroff, Klemens
    Brashear, Allison
    Maisonobe, Pascal
    Lysandropoulos, Andreas
    Ashford, Stephen
    JOURNAL OF REHABILITATION MEDICINE, 2021, 53 (02)
  • [8] Botulinum Toxin in the Treatment of Pediatric Upper Limb Spasticity
    Schwabe, Aloysia L.
    SEMINARS IN PLASTIC SURGERY, 2016, 30 (01) : 24 - 28
  • [9] Botulinum toxin type A treatment of upper limb spasticity
    Müller, J
    Wissel, J
    WIENER KLINISCHE WOCHENSCHRIFT, 2001, 113 : 16 - 19
  • [10] BOTULINUM-A-TOXIN TREATMENT OF UPPER LIMB SPASTICITY
    FRIEDRICH, H
    HESSE, S
    DOMASCH, C
    MAURITZ, KH
    AKTUELLE NEUROLOGIE, 1992, 19 (06) : 175 - 178
12345